Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2

Ítems similars

• Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer
  per: Sano, Kazumi, et al.
  Publicat: (2020)
• Major SNP (Q141K) variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
  per: Furukawa, Tomoka, et al.
  Publicat: (2008)
• Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer
  per: Takeda, Masayuki, et al.
  Publicat: (2017)
• Contrasting roles of the ABCG2 Q141K variant in prostate cancer
  per: Sobek, Kathryn M., et al.
  Publicat: (2017)
• Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
  per: Uchida, Junji, et al.
  Publicat: (2016)